The risk factors for arteriovenous fistula dysfunction in maintenance hemodialysis patients: A cross‐sectional study

Fan Zhang,Jie Yu,Guoli Li,Shuangshuang Fu,Hailang Xiao,Yiya Yang,Yumei Liang,Yinyin Chen,Xun Luo
DOI: https://doi.org/10.1111/hdi.13145
2024-03-08
Hemodialysis International
Abstract:Introduction Arteriovenous fistula (AVF) dysfunction is a prevalent complication among maintenance hemodialysis patients. However, the factors influencing AVF patency remain unclear. To address this, we conducted a study aimed at identifying factors contributing to AVF dysfunction in this patient population. Methods The study compared clinical data, vascular calcification score, and laboratory data focusing on blood cell composition and coagulation in 100 maintenance hemodialysis patients in whom an AVF had been inserted from January through September of 2022. The patients were divided into a group in which the AVF functioned without issues and a group in which the AVF was dysfunctional, defined as not able to provide a blood flow of greater than 200 mL/min. Findings Patients in the 2 groups (56 in the dysfunctional AVF group and 44 in the group with satisfactory AVF function) were similar demographically. Compared with the normally functioning AVF group, the AVF dysfunction group exhibited significantly higher Agatston calcium scores (20.5 [1.28, 298] median [Q1, Q3] vs. 1.14 [0.00, 11.6]; p = 0.01), elevated triglyceride levels (1.1 [0.6, 1.2] mmol/L vs. 0.5 [0.3, 0.8]; p
urology & nephrology
What problem does this paper attempt to address?